BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1430788)

  • 21. Levels of thymidylate synthetase during normal culture growth of L1210 cells.
    Cadman E; Heimer R
    Cancer Res; 1986 Mar; 46(3):1195-8. PubMed ID: 3943093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiostrongylus cantonensis: characterization of thymidylate synthetase.
    So NN; Wong PC; Ko RC
    Exp Parasitol; 1994 Dec; 79(4):526-35. PubMed ID: 8001663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic complementation and resistance to 5-fluoro-2'-deoxyuridine in thymidine auxotrophs expressing a highly defective mutant of human thymidylate synthase.
    Zapf JW; Zhao PS; Steadman DJ; Berger SH
    Biochem Pharmacol; 1999 Sep; 58(6):973-81. PubMed ID: 10509749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.
    Yalowich JC; Kalman TI
    Biochem Pharmacol; 1985 Jul; 34(13):2319-24. PubMed ID: 3160352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylcobalamin corrects the deleterious in vitro effect of nitrous oxide on thymidylate synthetase.
    Haurani FI; Kauh YS; Abboud EM
    Mol Cell Biochem; 1985 Jan; 65(2):153-7. PubMed ID: 3982397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
    FitzGerald GB; Ratliff J; Wick MM
    Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells.
    Ayusawa D; Koyama H; Seno T
    Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts.
    Fernandes DJ; Cranford SK
    Anal Biochem; 1984 Nov; 142(2):378-85. PubMed ID: 6241433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthesis and utilization via the de novo pathway in normal and megaloblastic human bone marrow cells.
    Matthews JH; Armitage J; Wickramasinghe SN
    Eur J Haematol; 1989 Apr; 42(4):396-404. PubMed ID: 2721662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidine 5'-monophosphate-requiring mutants of Saccharomyces cerevisiae are deficient in thymidylate synthetase.
    Bisson L; Thorner J
    J Bacteriol; 1977 Oct; 132(1):44-50. PubMed ID: 334734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased thymidylate synthetase activity in 5-fluorodeoxyuridine-resistant Novikoff hepatoma cells.
    Wilkinson DS; Solomonson LP; Cory JG
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):368-71. PubMed ID: 191843
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells.
    Jastreboff MM; Kedzierska B; Rode W
    Biochem Pharmacol; 1983 Jul; 32(14):2259-67. PubMed ID: 6223641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased thymidylate synthetase in 5-fluorodeoxyuridine resistant cultured hepatoma cells.
    Priest DG; Ledford BE; Doig MT
    Biochem Pharmacol; 1980 Jun; 29(11):1549-53. PubMed ID: 6446915
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and evaluation of 6-aza-2'-deoxyuridine monophosphate analogs as inhibitors of thymidylate synthases, and as substrates or inhibitors of thymidine monophosphate kinase in Mycobacterium tuberculosis.
    Kögler M; Busson R; De Jonghe S; Rozenski J; Van Belle K; Louat T; Munier-Lehmann H; Herdewijn P
    Chem Biodivers; 2012 Mar; 9(3):536-56. PubMed ID: 22422522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
    Davis ST; Berger SH
    Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of 5-fluorodeoxyuridine 5'-monophosphate deoxyuridine 5'-monophosphate pools following 5-fluorouracil.
    Myers CE; Young RC; Johns DG; Chabner BA
    Cancer Res; 1974 Oct; 34(10):2682-8. PubMed ID: 4278001
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of thymidylate synthetase of the human lymphocytes.
    Haurani FI
    Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase.
    Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF
    Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.